Patent Assignment
Reel/Frame 048809/0896
Assignment of Assignor's Interest
Recorded: 2019-04-05
Pages: 4
Assignee
AMAL THERAPEUTICS SA
64 AV. DE LA ROSERAIE, GENEVA, CH-1205, SWITZERLAND
Covered Property
(1)
Fusion Comprising A Cell Penetrating Peptide, A Multi Epitope And A TLR Peptide Agonist For Treatment Of Cancer
Application:
16/331,398 →
Publication:
US 2019/0255165